Abstract
Predictive models of nanoparticle transport can drive design of nanotherapeutic platforms to overcome biological barriers and achieve localized delivery. In this paper, we demonstrate the ability of artificial neural networks to predict both nanoparticle properties, such as size and protein adsorption, and aspects of the brain microenvironment, such as cell internalization, viscosity, and brain region by using large (>100 000) trajectory datasets collected via multiple particle tracking in in vitro gel models of the brain and cultured organotypic brain slices. Our neural network achieved a 0.75 recall score when predicting gel viscosity based on trajectory datasets, compared to 0.49 using an obstruction scaling model. When predicting in situ nanoparticle size based on trajectory datasets, neural networks achieved a 0.90 recall score compared to 0.83 using an optimized Stokes–Einstein predictor. To distinguish between nanoparticles of different sizes in more complex nanoparticle mixtures, our neural network achieved up to a recall score of 0.85. Even in cases of more nuanced output variables where mathematical models are not available, such as protein adhesion, neural networks retained the ability to distinguish between particle populations (recall score of 0.89). These findings demonstrate how trajectory datasets in combination with machine learning techniques can be used to characterize the particle-microenvironment interaction space.
Introduction
Nanotherapeutics have shown promise in their ability to enhance the efficacy of small molecule drugs and biologics in vivo, either through improved targeting, reduced toxicity, or enhanced drug stability.1 Since the FDA approval of liposomal doxorubicin in 1995 as a nanotherapeutic, 50 new nanoparticle-based drugs have entered the market, as of 2016.2 Yet, an unrealized promise of nanotherapeutics is the ability to decouple transport properties from their therapeutic effect. A better understanding of this relationship would allow researchers to make precision changes to nanotherapeutic characteristics to tune delivery and provide the most efficacious formulation for the target disease without needing to change the therapeutic agent. In order to achieve successful delivery, a nanoparticle formulation must be optimized to achieve localized delivery, evade immune detection, cross biological barriers, and minimize off-target effects.3 Many studies have investigated nanoparticle transport methods using empirical approaches to measure nanoparticle transport properties in in vitro, ex vivo, and in vivo models,4-6 while others have developed theoretical and computational models examining local phenomena and systems-wide behavior.7,8 A fourth paradigm that we seek to implement here is the use of machine learning methods on large (104–106 trajectories) experimental datasets of nanoparticle transport properties in in vitro and ex vivo models to build predictive models of nanoparticle behavior.
Multiple particle tracking (MPT) is a characterization technique used in many biological domains. MPT relies upon tracking the microscopic motion of hundreds to thousands of individual particles simultaneously in real-time using video microscopy. Investigators can use the resulting nanoparticle trajectory datasets to obtain mean-squared displacement (MSD) profiles and diffusion coefficients (Deff) as well as geometric features such as trajectory boundedness and asymmetry. MPT is responsible for a number of discoveries, including the mechanical properties of living cells,9 size selectivity of mucosal layers,10,11 and extracellular pore size of various tissues.6,12 Collectively, these findings give insights into design principles that result in optimal delivery to target sites. However, these datasets mostly take the form of heuristics rather than empirical and theoretical models that can be optimized with computational approaches. This leaves a large unexplored design space and opportunity for more comprehensive and adaptive models of nanoparticle property-environment interaction systems.
The use of trajectory datasets from MPT has primarily been limited to calculating ensemble-level Deff and MSD profiles. As MPT datasets can be quite large (102–105 trajectories per experiment), they are a clear candidate for the incorporation of data science methods to investigate trends and make predictions. In this paper, we use neural networks to predict both nanoparticle properties and properties of the surrounding microenvironment from input nanoparticle trajectory datasets. From experimentally generated nanoparticle trajectories, we demonstrate the ability to predict nanoparticle size, whether or not a nanoparticle has been internalized by a cell, and whether or not a particle was pre-incubated with serum prior to use. This is non-trivial, due to the heterogeneity of nanoparticle behavior and the interacting effects of nanoparticle properties and the microenvironment on nanoparticle transport. Further, we introduce a collection of MPT and downstream analysis tools in a Python-based diff_classifier package for high-throughput analysis of nanoparticle diffusion datasets.
Results and discussion
Neural network predictors of nanoparticle size using MPT datasets
First, we sought to examine whether machine learning techniques can be used to distinguish nanoparticle properties from MPT trajectory datasets. We selected nanoparticle size, a nanoparticle property which can directly correlate to diffusive behavior with theory. We performed diffusion experiments in 0.4% agarose gels using three different diameters of PS-COOH nanoparticles: 100, 200, and 500 nm (Fig. 1a). Hydrodynamic size distributions of each particle type were obtained via DLS and are shown in Fig. 1b. An initial comparison of geometric ensemble average mean squared displacement (〈MSD〉) profiles is shown in Fig. 1c. For spherical particles diffusing in a free media, particle radius r is related to diffusion coefficient D by Stokes–Einstein:
where kB is Boltzmann’s constant, T is the absolute temperature, and η is the dynamic viscosity. In porous media such as agarose, the diffusion coefficient is referred to as an effective diffusion coefficient, Deff, and takes into account the gel’s tortuosity λ, a parameter describing the hindrance a particle experiences relative to diffusion in free media.13
For the purposes of our predictor, we initially assumed a tortuosity value of 1 (Deff = D), due to the low concentration of agarose used in our studies. As expected from Stokes–Einstein, the particles’ diffusive ability decreased with increasing particle size. The populations were distinct enough that particle size could be predicted with some accuracy without any additional information, using Deff only. By using Stokes–Einstein to calculate particle size based on Deff at a time lag of 100 ms and binning trajectories into three groups (<150, 150–350, and >350 nm), we built a predictor that achieved an average recall score (a non-binary version of the sensitivity, the ability of the classifier to find all positive samples) of 0.636 (Table 1). In the case of larger particle sizes (200 nm and 500 nm), the predictor overestimated Deff. This resulted in higher recall values for 500 nm nanoparticles (0.888) at the expense of lower recall values for 200 nm nanoparticles (0.278).
Table 1.
Sample size |
Stokes–Einstein Overall |
Stokes–Einsteina |
Stokes–Einsteina,b |
Neural networkb |
|||||
---|---|---|---|---|---|---|---|---|---|
Training | Test | Training | Test | Training | Test | Training | Test | ||
100 nm | 49 041 | 48 854 | 0.743 | 0.908 | 0.908 | 1.000 | 1.000 | 1.000 | 1.000 |
200 nm | 29 231 | 27 878 | 0.278 | 0.448 | 0.457 | 0.715 | 0.726 | 0.914 | 0.856 |
500 nm | 28 493 | 26 459 | 0.888 | 0.721 | 0.744 | 0.723 | 0.762 | 0.931 | 0.852 |
Avg/tot | 106 765 | 103 191 | 0.636 | 0.692 | 0.703 | 0.813 | 0.829 | 0.999 | 0.902 |
Predictions performed including an anomalous diffusion coefficient.
Predictions performed using locally averaged features.
In order to improve the performance of the predictor, we altered our analysis in two ways: first, the way the dataset was split into training and test populations was changed. Second, the assumption of no tortuosity (λ = 1) was re-examined. When selecting a training-test split, we chose to split the test dataset spatially based on the coordinates of the input trajectories in a checkerboard pattern rather than a random train-test split for two reasons: first, later predictors rely on locally averaged features. Using random train-test splits would cause contamination of the training dataset with information from the test dataset due to the use of local feature averages as inputs. Second, the spatial train-test split reflects more accurately sample-to-sample variability. Due to inherent batch-to-batch variability in gel samples,14 the predictor can be over-trained if not enough independent samples are included in the training dataset. While each square region isn’t an independent sample, there are regional differences that are better accounted for by a spatial split rather than a random split. For a more accurate estimate of tortuosity, we selected λ values for the predictor by minimizing the difference between median log(Deff) in each particle strata in the training dataset and the log(Deff) predicted by Stokes–Einstein. This resulted in a λ value of 1.33 and a predictor that achieved an average recall score of 0.703 in the test dataset, with recall scores of 0.457 for 200 nm nanoparticles and 0.744 for 500 nm nanoparticles (Table 1). By accounting for tortuosity, the Stokes–Einstein predictor improved overall predictive power by increasing the number of correctly identified 100 nm and 200 nm nanoparticles (22% and 64% increase, respectively) at the expense of mislabeling a small percentage of 500 nm nanoparticles (16% decrease).
The Stokes–Einstein based predictor was further improved by calculating Deff based on local averages over 9 μm × 9 μm windows rather than Deff of individual trajectories. Each video was split spatially into 256 9 μm × 9 μm regions and the average features in each region were calculated. Each trajectory was then characterized by a locally averaged Deff within its corresponding region. This minimized some of the noise inherent in MPT datasets. Using the updated local averaging/anomalous diffusion configuration, we performed a regional training-test split like the one performed previously and found a λ value of 1.26 for the training dataset. The new predictor achieved an average recall score of 0.829 in the test dataset (Table 1). While this exceeds the performance of a random guess (recall score of 0.333), such accurate results would not carry over to experiments with a wider range of particle sizes. For example, samples with intermediate particles sizes (such as the 200 nm particles with a recall score of 0.726) are difficult to distinguish due to high variances in Deff distributions. Additionally, the ability to resolve trajectories will also be limited at the large nanoparticle limit as the distance travelled by the nanoparticle approaches the image resolution (0.07 μm per pixel for all videos in this paper). We aimed to improve performance by accounting for factors other than the raw Deff and incorporating a machine learning model.
In addition to generating 〈MSD〉 profiles and raw Deff distributions, 17 distinct features were calculated for each individual trajectory (Table S1†). A principle component analysis (PCA) was then run on the composite dataset of individual features and locally averaged features. The sampling adequacy was verified via the Kaiser-Meyer-Olkin (KMO) criterion (KMO = 0.919). PCA yielded 11 primary components to achieve 81.3% explained variance. Average component scores and component distributions from the PCA are shown in Fig. 1e, f, and the primary contributing features to each component as well as the explained variance are shown in Table 2. This breakdown of the principle components gives a semi-quantitative analysis of the overall contribution of each component to the model. For instance, the first component accounting for 30.6% of the total variance captures contributions from the mean efficiency, the mean straightness, and the mean Deff1. The second component, accounting for 15.3% of the total variance, captures contributions from the three mean asymmetry measures and the mean elongation. And the third component, accounting for 7.9% of the total variance, captures contributions from the asymmetry measures prior to averaging. Using the first three components, each particle type forms distinct clusters (Fig. 1g). There is very little overlap between the three populations, with a distinct boundary between the 100 nm population and the 200 and 500 nm populations.
Table 2.
Principle components | Primary contributing features | Explained variance |
||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ||
0 | Mean efficiency | Mean Straightness | Mean Deff1 | Mean fractal_dim | Mean D_fit | 30.6 |
1 | Mean asymmetry3 | Mean elongation | Mean asymmetry2 | Mean asymmetry1 | Mean AR | 15.3 |
2 | Asymmetry1 | Asymmetry2 | Asymmetry3 | Efficiency | Elongation | 7.9 |
3 | Std asymmetry3 | Std elongation | Std asymmetry2 | Std asymmetry1 | Std AR | 5.9 |
4 | Frames | Mean kurtosis | Trappedness | Boundedness | Std kurtosis | 4.2 |
5 | Mean kurtosis | Std kurtosis | Std MSD_ratio | Mean MSD_ratio | Alpha | 3.8 |
6 | Alpha | D_fit | MSD_ratio | Asymmetry1 | Asymmetry2 | 3.5 |
7 | Std MSD_ratio | Mean MSD_ratio | Std kurtosis | Mean kurtosis | Trappedness | 3.0 |
8 | Kurtosis | Frames | Fractal_dim | Std MSD_ratio | Std fractal_dim | 2.5 |
9 | Mean frames | Std alpha | Std frames | Std boundedness | Std trappedness | 2.4 |
10 | Kurtosis | Std MSD_ratio | Std fractal_dim | Deff1 | Std boundedness | 2.3 |
Using all 51 components as inputs (17 individual trajectory features and 34 locally averaged features), we built a neural network classifier using the checkerboard train-test split described above. The neural network classifier was able to predict particle size with a 0.902 average recall score in the test dataset, with recall scores of 1.000, 0.856 and 0.852 for the 100 nm, 200 nm and 500 nm nanoparticles, respectively (Table 1). By implementing a neural network using trajectory feature datasets, we were able to achieve high predictive ability in determining nanoparticle size. The ability to resolve particle sizes at the micron level in an in vitro model of the brain microenvironment demonstrates one aspect of the utility of nanoparticles as probes. We were able to directly compare neural network performance with expected results from theory. However, these predictors will have little practical value unless they can be used in more complex environments. For example, one test case would be mixtures of particles of different sizes. We investigated the case of 40 nm/100 nm and 40 nm/200 nm mixtures to determine whether we could distinguish between the two particle sizes when the particles were mixed together. Without performing any local averaging, the neural network predictor achieved an average recall value of 0.846 (40 nm: 0.858, 200 nm: 0.834) for the 40/200 mixture and 0.714 (40 nm: 0.773, 100 nm: 0.655) for the 40/100 mixture (Fig. S1 and Tables S2, S3†). Similar neural network predictors could be used to predict particle size of polydisperse samples in more complex media environments without access to the “true” value. For example, users could track changes in particle size distributions during an aggregation event. Neural network predictors could prove useful in cases where size measurements are required, but nanoparticle samples cannot be extracted for measurement by standard techniques, such as dynamic light scattering. Additionally, size could be quantified in environments not suitable for size measurements, such as gels or ex vivo tissue slices, as demonstrated in this study.
Neural network predictors of nanoparticle surface functionality and protein corona in an in vitro agarose gel model
Next, we wanted to predict a more nuanced nanoparticle property using MPT datasets. It is known that in biological environments, the properties of the nanoparticle surface affect its ability to diffuse.6,12,15 However, to our knowledge, there are no theoretical or empirical models relating the diffusive properties of a nanoparticle to its surface functionality or material properties. As surface properties are a more multi-dimensional feature space (e.g. surface charge, hydrophobicity, ligand density) and oftentimes depend on the surrounding environment, it is difficult to create a model accounting for all possible permutations.3 We chose to examine the effect of two nanoparticle properties on their diffusive ability: surface PEGylation and adhered surface proteins. Nanoparticle PEGylation is a common method used to evade the immune system,16 as well as to improve colloidal stability.17 PEGylation has also been shown to improve the ability of nanoparticles to penetrate complex systems, including mucus,15 vitreous,12 tumors,18 and the brain parenchyma.19 In biological environments, nanoparticles accumulate a layer of proteins known as the protein corona.20,21 This can alter aggregation rates, cell internalization, and transport properties.22 For instance, protein coatings have been demonstrated to increase the time scale over which nanoparticles interact with cells23 and strongly reduce nanoparticle adhesion to cellular surfaces.24 We incubated PS-COOH and PS-PEG nanoparticles in horse serum to create a protein corona on the particle surface. DLS measurements quantified a change in particle size and zeta potential. PS-COOH nanoparticles increased in size from 142.0 ± 4.2 to 2583 ± 441 nm and ζ-potential increased from −40.4 ± 2.8 to −12.3 ± 1.2 mV; PS-PEG nanoparticles increased in size from 163.2 ± 1.5 to 408.2 ± 87.7 nm and ζ-potential decreased from −6.2 ± 2.5 to −9.4 ± 0.9 mV (Fig. 2b and c). We further confirmed protein adhesion via bicinchoninic acid (BCA) assay. An average of 47.0 ± 2.5 × 10−11 μg protein was found on the surface of each PS-COOH nanoparticle compared to 10.0 ± 0.3 × 10−11 μg per particle for PS-PEG nanoparticles (Fig. 2d).
We hypothesized that the protein corona would change how nanoparticles behaved in an agarose matrix, exhibiting higher Deff than non-coated particles due to reduced interactions with agarose chains. MPT experiments resulted in 〈MSD〉 profiles of similar magnitudes (Fig. S2a†), with geometric ensemble-averaged Deff at τ = 1 s of 0.74 and 1.07 μm2 s−1 for serum-free and serum-incubated PS-COOH nanoparticles, respectively, and 0.93 and 1.78 μm2 s−1 for serum-free and serum-incubated PS-PEG nanoparticles, respectively. The serum-incubated particles had higher diffusivities when compared with particles not incubated in serum, especially in the case of PS-PEG nanoparticles. The higher diffusivities of serum-incubated particles in agarose gels align with previous in vitro cell experiments performed by Lesniak et al.24 In non-aggregating conditions, PS-PEG and PS-COOH have been shown to have diffusive behavior of similar magnitudes,17 and our findings match these previous results.
With the resulting trajectory feature datasets, PCAwas performed as described above for the size-dependent study. The sampling adequacy was verified via the KMO criterion (KMO = 0.864). The PCA yielded 13 primary components to achieve 81.2% explained variance. Average component scores and component distributions from the PCA are shown in Fig. S2b and c.† Using the first three components, each particle type formed distinct clusters as shown in Fig. S2d.† Using a trained neural network, we predicted particle type (PS-COOH, PS-COOH in serum, PS-PEG, and PS-PEG in serum) with an average recall score of 0.885 in the test dataset (Table 3). This demonstrates the predictive power that can be leveraged when using trajectory features other than just Deff, as implemented in the Stokes–Einstein size predictors in the previous study. A predictor based on log median Deff using locally averaged trajectory features is not able to parse out these differences, with an average recall score of 0.427 (Table 3). As the 〈MSD〉 profiles are of similar magnitude for all four particle types (Fig. 2a), one wouldn’t expect that such a predictor would perform very well.
Table 3.
Sample size |
Median predictora |
Neural networka |
||||
---|---|---|---|---|---|---|
Training | Test | Training | Test | Training | Test | |
PS-COOH | 134 717 | 135 518 | 0.329 | 0.324 | 1.000 | 0.902 |
PS-COOH in serum | 191 947 | 191654 | 0.357 | 0.374 | 1.000 | 0.916 |
PS-PEG | 52 038 | 51 917 | 0.166 | 0.191 | 0.998 | 0.741 |
PS-PEG in serum | 351 935 | 352 061 | 0.828 | 0.821 | 1.000 | 0.981 |
Avg/tot | 730 637 | 731 150 | 0.420 | 0.427 | 0.998 | 0.885 |
Predictions performed using locally averaged features.
The fact that such nuanced nanoparticle properties such as surface functionality and protein adsorption can be resolved using an indirect measurement technique such as MPT is very promising. This leaves room to probe additional nanoparticle properties, such as the effect of nanoparticle composition, shape, density, and porosity on nanoparticle transport behavior. Additionally, this method can be extended to provide systems-wide predictive models that account for a host of particle parameters.
Neural network predictors of nanoparticle surface functionality and protein corona in an ex vivo brain tissue slice model
While we have demonstrated the ability to differentiate between nanoparticle properties using MPT datasets and neural network, we wanted to test to what extent such predictive ability was preserved in a more physiologically relevant model. Agarose gels can capture some aspects of the tissue microenvironment, such as ionic composition and viscoelastic properties, but they are not dynamic and neglect interactions with cells and proteins. We hypothesized that MPT could also be used to detect the extent of these interactions, given that protein adsorption has been shown to decrease nanoparticle interactions with cell membranes.24 Both a computational and experimental approach were used to test this hypothesis. Computationally, we used a random walker model where nanoparticles were capable of adhering to cells, modeled as squares, to demonstrate the impact that adhesion interactions of varying strength have on 〈MSD〉 profiles (Fig. 3b). Adhesion interactions are represented as the probability a random walker will “stick” when encountering a surface while diffusing. When this sticking probability increased (10%, 20%, 30%, 50%, 75%, 90%, 99%), the Deff decreased by a factor of 0.00, 0.01, 0.02, 0.02, 0.05, 0.27, and 5.56, respectively, when compared to particles with a sticking probability of 1%. We repeated this experiment with a 2-fold narrower spacing between “cells”, and it resulted in an even stronger effect. In this scenario, Deff decreased by a factor of 0.00, 0.00, 0.04, 0.05, 0.18, 0.47, and 14.07, respectively, when compared to particles with a sticking probability of 1%.
To capture some of the biological effects ignored by the agarose gel model, an ex vivo rat brain slice model was used. Unlike in the gel experiment, we saw a bifurcation between PS-COOH and PS-PEG particles. We calculated geometric ensemble-averaged Deff at τ = 1 s of 0.0093 and 0.018 μm2 s−1 for serum-coated PS-COOH and serum-free PS-COOH, respectively, and Deff of 0.61 and 0.22 μm2 s−1 for serum-coated PS-PEG and serum-free PS-PEG, respectively (Fig. 3d). In tissue, the PS-COOH particle types with and without serum were more immobile compared to gel studies. Here, we calculated Deff of 0.0093 and 0.018 μm2 s−1 for serum-coated PS-COOH and serum-free PS-COOH, respectively, in tissue, and 1.07 and 0.74 μm2 s−1 for serum-coated PS-COOH and serum-free PS-COOH, respectively, in gels. This has been shown in previous experiments, as PS-COOH nanoparticles are subject to both electrostatic and hydrophobic interactions with various components of the brain microenvironment, hindering their diffusive ability.17 Contrary to experiments run in gel, the protein corona did not uniformly increase ensemble nanoparticle diffusive behavior. On average, serum-incubated PS-COOH nanoparticles had lower MSD profiles than their serum-free counterparts, while incubation with serum increased the diffusivities of PS-PEG nanoparticles (Fig. S3a†). It has previously been shown that altering PEG grafting density on a nanoparticle surface can influence both total protein adsorption and protein corona composition, and subsequently affect cellular uptake.25 To explain the diverging behavior in nanoparticle diffusion in greater detail, fluorescence activated cell sorting (FACS) was used to evaluate the cellular uptake profiles of each type of nanoparticle (Fig. 3c; example raw FACS data found in Fig. S4†). It was determined that 8.7 ± 0.8% of Cd11b+ macrophages took up PS-PEG nanoparticles, compared to 2.0 ± 0.3% for serum-incubated PS-PEG nanoparticles. The opposite effect was observed for PS-COOH nanoparticles, where 12.2 ± 1.7% of macrophages took up the serum-free PS-COOH nanoparticles compared to 21.3 ± 1.0% uptake for serum-incubated PS-COOH particles. Particles confined in cells and internal cellular compartments have restricted trajectories and reduced Deff, suggesting that any differences we observed in ex vivo particle behavior could in turn be caused by cellular internalization.26,27
The sampling adequacy was verified via the KMO criterion (KMO = 0.907). The PCA yielded 12 primary components to achieve 80.9% explained variance. Average component scores and component distributions from the PCA are shown in Fig. S3b and c.† We plotted the first three components against each other in Fig. S3d,† where we saw significant overlap between the four populations, and the serum-incubated PS-PEG population was difficult to distinguish. Using all 51 components as inputs, we built a neural network classifier that was able to predict particle type with a 0.591 average recall score in the test dataset (Table 4). Our ability to predict particle type accurately was significantly reduced in comparison to the results in gels. This is partly due to the more significant inter-sample variation in particle behavior. A major contributor to the poor performance of the neural network classifier was the inability to distinguish the PS-PEG population, which had a recall score of 0.283. However, this method still outperforms a classification based on binning by median Deff (Fig. 3d) with an average recall score of 0.110 in the test dataset. While it is reassuring that the predictor can still make accurate predictions despite intra-sample variability, it also raises concerns whether this prediction would be reproducible across slices outside of the training dataset.
Table 4.
Sample size |
Median predictora |
Neural networka |
Neural networka,b |
Neural networka,b,c |
Neural networka,b,d |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Training | Test | Training | Test | Training | Test | Training | Test | Training | Test | Training | Test | |
PS-COOH | 88 001 | 86 429 | 0.083 | 0.075 | 0.773 | 0.593 | 0.807 | 0.473 | 0.886 | 0.536 | — | — |
PS-COOH in serum | 138 913 | 142 066 | 0.176 | 0.172 | 0.842 | 0.687 | 0.878 | 0.548 | 0.936 | 0.640 | — | — |
PS-PEG | 35 969 | 36 864 | 0.142 | 0.171 | 0.438 | 0.283 | 0.517 | 0.065 | — | — | 0.658 | 0.258 |
PS-PEG in serum | 95 111 | 93 907 | 0.029 | 0.023 | 0.879 | 0.800 | 0.878 | 0.641 | — | — | 0.967 | 0.908 |
Avg/tot | 357 994 | 359 266 | 0.107 | 0.110 | 0.838 | 0.591 | 0.770 | 0.432 | 0.911 | 0.588 | 0.812 | 0.583 |
Predictions performed using locally averaged features.
Reported recall values are averaged from 4 separate 3–1 train-test split predictors.
Predictor limited to PS-COOH nanoparticles to predict serum status.
Predictor limited to PS-PEG nanoparticles to predict serum status.
In order to test the ability of our neural network to predict particle type in slices not included in the training dataset, we selected a new training/test configuration. We trained our neural network on 3 of 4 slices for each particle type and reserved one slice as a test dataset. This was repeated four times, such that each slice was used once as a test dataset. In this case, we were able to retain some of our predictive ability. We generated a range of average recall scores of 0.402–0.513 in the test dataset, but we had a complete loss of predictive ability of serum-free PS-PEG nanoparticles, with a range of recall scores of 0.039–0.105 (Table S4†). If we limit our predictions to incubation status (serum-free or serum-incubated), this configuration provides predictive ability for the test datasets with 0.480–0.706 average recall scores for PS-COOH nanoparticles (Table S5†), and 0.479–0.690 average recall scores for PS-PEG nanoparticles (Table S6†). When predicting serum status in the PS-PEG particle population, our neural network configuration still could not resolve serum-free particles, with recall scores of 0.071–0.535. Our results indicate that while there are measurable differences between particle populations, the amount of inter-sample variability hinders the utility of such predictors. We could resolve this further with very large training datasets, but this is not likely to be a cure-all, as serum-free PS-PEG particles had low recall scores even without accounting for intra-sample variability. As we have demonstrated that there are significant differences in cell uptake between serum-free and serum-incubated nanoparticles, neural network predictors could be improved by incorporating information relating to nanoparticle–cell interactions. For instance, complementary histology can be included in input datasets to improve predictive ability.
Neural network predictors of gel stiffness using MPT datasets
Next, we sought to demonstrate that nanoparticle probes can also be used to predict aspects of their surrounding environment. If we could demonstrate that subtle differences in the surrounding tissue microenvironment could be differentiated solely with MPT trajectory datasets, this could potentially be used as a powerful preclinical diagnostic tool. We first chose a simple and controllable model with a tunable parameter: agarose gels with varying agarose concentrations to adjust gel stiffness and porosity. Low concentration agarose gels have been used as a model of brain tissue because they have similar infusion properties28 and pore sizes29 to the brain microenvironment. By varying agarose concentration, we can mimic changes in the brain microenvironment that may occur in disease states30 or aging processes.31 To model this computationally, we used a random walker model with increasingly densely packed “sticky” particulates to demonstrate the impact of varyingly dense microenvironments on diffusive ability (Fig. 4b). Particulate concentrations were increased 4-, 8-, 12-, 16-, 20-, 24-, 28-, 32-, and 36-fold in each simulation resulting in 0.09-, 0.20-, 0.32-, 0.71-, 1.15-, 2.01-, 3.45-, 5.81-, and 6.82- fold decreases, respectively, in ensemble-averaged Deff. This general trend is likely to hold in in vitro experiments.
We chose a range of agarose concentrations from 0.4 to 1.2 weight % agarose that encompass concentrations found to mimic infusion properties of the brain.28 We use 0.2% agarose intervals to test the resolution limits of our neural network predictors. An oscillatory rheological analysis was performed on each weight % agarose gel to verify the storage moduli increased with increasing agarose concentration (Fig. 4d and Fig. S5†). An initial comparison of 〈MSD〉 profiles generated from MPT experiments performed in each gel is shown in Fig. S6a.† As expected, the nanoparticles’ diffusive ability decreased with increasing agarose concentration, with calculated geometric ensemble-averaged Deff at τ = 1 s of 0.51, 0.43, 0.23, 0.22, and 0.17 μm2 s−1 for 0.4%, 0.6%, 0.8%, 1.0%, and 1.2% agarose gels, respectively (Fig. 4d). However, these differences are much smaller in magnitude compared to the differences caused by particle size. Similar to the particle size experiment, we built a baseline predictor using theory with which we could compare the neural network predictive ability. The Deff of nanoparticles diffusing in porous media is related to the volume fraction of polymer gel by the following obstruction scaling model:
where Dg is the diffusion coefficient in the gel, D0 is the diffusion coefficient in water, rs is the nanoparticle radius, rf is the radius of the polymer chain, ks is a constant of proportionality, a is the equivalent bond length of the monomer, ϕ is the volume fraction of polymer in the gel, C∞ is the characteristic ratio of the polymer, and χ is the Flory–Huggins interaction parameter.32
Using the percent agarose values and the calculated Deff of the nanoparticle trajectories at τ = 100 ms, we fit the model using a nonlinear curve fit. We calculated percent agarose concentrations for each trajectory in the whole dataset and binned trajectories into five groups: <0.5%, 0.5–0.7%, 0.7–0.9%, 0.9–1.1%, and >1.1%. This predictor achieved an average recall score of 0.218 (Table 5). If we reduce the resolution and only look at the 0.4, 0.8, and 1.2% samples, we get an average recall score of 0.367, which is not competitive with a random guess, which has an average recall score of 0.333. If, in addition to reduced resolution, we use locally averaged Deff, we obtain an average recall score of 0.488. The predictor had the most difficulty predicting intermediate agarose concentrations (e.g. 0.228 for trajectories in 0.8% agarose). Predicting viscoelastic properties of the surrounding media proves to be a more difficult problem than predicting particle size and leaves room for ongoing exploration using a neural network classifier on input trajectory datasets.
Table 5.
Sample size |
Obstruct. model Overall |
Obstruct. modela Overall |
Obstruct. Modelb Overall |
Obstruct. Modela,b Overall |
Neural networkb |
Neural Networka,b |
||||
---|---|---|---|---|---|---|---|---|---|---|
Training | Test | Training | Test | Training | Test | |||||
0.4% | 44 643 | 45 388 | 0.409 | 0.420 | 0.623 | 0.712 | 0.910 | 0.695 | 0.992 | 0.834 |
0.6% | 42 941 | 41 812 | 0.061 | — | 0.235 | — | 0.843 | 0.486 | — | — |
0.8% | 46 913 | 45 652 | 0.164 | 0.316 | 0.121 | 0.228 | 0.805 | 0.329 | 0.974 | 0.569 |
1.0% | 63 001 | 65 820 | 0.151 | — | 0.027 | — | 0.880 | 0.395 | — | — |
1.2% | 122 390 | 121 818 | 0.304 | 0.365 | 0.502 | 0.524 | 0.972 | 0.702 | 0.996 | 0.837 |
Avg/tot | 180 610 | 181 437 | 0.218 | 0.367 | 0.302 | 0.488 | 0.882 | 0.521 | 0.987 | 0.747 |
Predictor trained using only 0.4%, 0.8%, and 1.2% datasets (reduced resolution).
Predictions performed using locally averaged features.
A PCA yielded 14 primary components to achieve 81.7% explained variance. Average component scores and component distributions from the PCA are shown in Fig. S6b and c.† Using the first three components plotted against each other, distinct regions can be observed (Fig. S6d†), but the intermediate gel viscosities, particularly the 0.6% and 0.8%, are difficult to distinguish visually. Using all 51 components as inputs, we built a neural network classifier that was able to predict agarose concentration with a 0.521 average recall score in the test dataset (Table 5). The predictor was able to resolve trajectories in both high and lower agarose concentrations, with recall scores of 0.695 and 0.702 in 0.4% and 1.2% agarose, respectively. However, the neural network predictor lost power at intermediate agarose concentrations, with recall scores of 0.486, 0.329, and 0.395 for 0.6, 0.8, and 1.0% agarose concentrations, respectively. If we reduce the resolution and only include 0.4, 0.8, and 1.2% samples, we achieved an average recall score of 0.747 in the test dataset. This predictor still suffers at intermediate concentrations with a 0.569 recall score for 0.8% agarose, but the neural network is still able to outperform the obstruction model predictor. This demonstrates the potential power of using trajectory datasets to predict aspects of the surrounding environment. Additional factors that could be probed are changes in surface charge and hydrophobicity of gel components, heterogeneity of gels, and the composition of the surrounding media.
Neural network predictors of nanoparticle surface functionality and cell uptake status using MPT datasets
Next, we wanted to build a predictor that would be able to distinguish both nanoparticle properties and aspects of the surrounding environment. Nanoparticle behavior is a function of the surrounding environment, and if we hope to build predictive models that are useful in more complex environments, it is important that we can capture these interactive effects. We sought to demonstrate the ability to predict particle internalization into a cell by using trajectory feature datasets using two different particle types, PS-COOH and PS-PEG. Even without accounting for the complex biology involved, we can predict distinct diffusive behavior due solely to geometric constraints. For example, Brownian motion confined to a circle of radius rc2 can be modeled by:
where D is the diffusion coefficient, n is the frame, Δt the shutter speed, and A1 and A2 are shape constants.26 Nanoparticles in cells will likely not only be confined within the cell membrane but will also be internalized into organelles, resulting in hindered diffusive behavior.33 As observed previously, surface charge impacts both interactions with cells and cell uptake profiles. We sought to build a predictor that would be able to determine whether a particle has been internalized based on its trajectory features.
In this experiment, BV-2 cells were exposed to PS-COOH or PS-PEG nanoparticles for 1 h prior to imaging. Using binary images generated from brightfield images of cells taken directly after tracking experiments (Fig. 5b and c), trajectories were labelled as either “in cells” or “out of cells”. Ensemble-averaged MSDs of PS-COOH and PS-PEG nanoparticles stratified by cell internalization are shown in Fig. S7a.† Nanoparticles in cells consistently had lower Deff than their uninternalized counterparts. We calculated 0.00088 and 69 μm2 s−1 geometric ensemble-averaged Deff for PS-COOH nanoparticles “in cells” and “out of cells”, respectively, and 0.0025 and 1.08 μm2 s−1 for PS-PEG nanoparticles “in cells” and “out of cells”, respectively. 〈MSD〉 profiles of non-internalized PS-COOH and PS-PEG cells are of similar magnitude.
We performed a PCA on the composite dataset of individual features and locally averaged features. The sampling adequacy was verified via the KMO criterion (KMO = 0.948). The PCA yielded 13 primary components to achieve 80.7% explained variance. Average component scores and component distributions from the PCA are shown Fig. S7b and c.† Using the first three components, each particle type forms distinct clusters (Fig. S7d†), where there is overlap between the four populations, but each population can be resolved visually. Using all 51 components as inputs we built a neural network classifier that was able to predict particle type/cell internalization with a 0.686 average recall score in the test dataset (Table 6). Internalized PS-PEG nanoparticles were the most difficult to resolve, with a recall score of 0.412 in the test dataset. This is likely due to three causes: (1) there are very few internalized PS-PEG nanoparticles, and thus a small training dataset (Fig. 5d), (2) there is less of a binary behavior of PS-PEG nanoparticles “in cells” and “out of cells”, and (3) any immobilized PS-PEG nanoparticles in cells are difficult to distinguish from immobilized PS-COOH nanoparticles in cells. While PS-COOH internalized particles are almost uniformly immobile and the non-internalized PS-COOH particles are free to move the internalized PS-PEG nanoparticles have broader distribution in diffusive behavior (Fig. 5d).
Table 6.
Sample size |
Median predictora |
Neural networka |
Neural networka, b |
Neural networka, c |
Neural networka,c,d |
Neural networka,c,e |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Training | Test | Training | Test | Training | Test | Training | Test | Training | Test | Training | Test | Training | Test | |
COOH out of cells | 65 458 | 65 174 | 0.157 | 0.170 | 0.838 | 0.699 | 0.898 | 0.719 | 0.907 | 0.734 | 0.984 | 0.926 | — | — |
COOH in cells | 48 825 | 49 832 | 0.207 | 0.208 | 0.935 | 0.787 | 0.966 | 0.804 | 0.977 | 0.837 | 0.982 | 0.852 | — | — |
PEG out of cells | 56 517 | 57 097 | 0.159 | 0.154 | 0.946 | 0.847 | 0.965 | 0.850 | 0.973 | 0.865 | — | — | 0.985 | 0.979 |
PEG in cells | 9810 | 9334 | 0.276 | 0.210 | 0.623 | 0.412 | 0.709 | 0.434 | 0.754 | 0.439 | — | — | 0.766 | 0.724 |
Avg/tot | 180 610 | 181 437 | 0.200 | 0.185 | 0.836 | 0.686 | 0.885 | 0.702 | 0.903 | 0.719 | 0.983 | 0.889 | 0.875 | 0.852 |
Predictions performed using locally averaged features.
Trajectories within 10 pixels of a cell surface were excluded from predictions.
Trajectories within 20 pixels of a cell surface were excluded from predictions.
Predictor limited to PS-COOH nanoparticles to predict cell uptake status.
Predictor limited to PS-PEG nanoparticles to predict cell uptake status.
Thus, the internalized PS-PEG nanoparticles can be mistaken by the network for both PS-PEG nanoparticles out of cells and PS-COOH nanoparticles in cells.
We also note that our ability to label particles as internalized and non-internalized is imperfect. Without a highly accurate reference standard, there will be trajectories falsely labelled as internalized due to imperfectly resolved cellular edges and variable particle behavior at cellular interfaces. Other trajectories will be falsely labelled as non-internalized due to thin cellular features that are lost in image processing steps (Fig. 5c). This will inevitably limit the accuracy of our neuraI network classifier. We were able to improve the performance of our neural network classifier by excluding particles near cellular interfaces. When we excluded particles within 10 pixels (0.7 μm), we achieved an average recall score of 0.702 and a recall score of 0.434 for internalized PS-PEG nanoparticles in the test dataset. When we excluded particles within 20 pixels (1.4 μm), we achieved an average recall score of 0.719 and a recall score of 0.439 for internalized PS-PEG nanoparticles in the test dataset. By excluding particles at the interface, we minimize errors due to variable behavior at cell interfaces and inaccurate binarization of the cellular images.
By implementing a neural network, we were able to achieve high predictive ability in determining cell internalization based on trajectory datasets. This could be expanded to include internalization in cellular substructures such as lysosomes and vacuoles. In cases where cell stains are available, using this information can allow for more powerful predictive models. For example, instead of predicting cell internalization, investigators could predict whether particles were sequestered in organelles, diffusing in the cytosol, associated with the cell membrane, or embedded in the extracellular matrix. Additional questions could probe the relationship of nanoparticle diffusion to cell type, phenotype, and intracellular protein distribution.
Conclusions
Traditional applications of MPT have a large amount of overhead. For example, a single experiment examining 4 different conditions and 3 replicates per condition can run upwards of 1 terabyte of data. From that terabyte of video, thousands to millions of trajectories are collected, all to report an often ensemble-averaged Deff value per condition. These large datasets are a prime target for machine learning methods. Trajectory datasets have been used in biological settings, for example, to classify motion types. Additionally, applications outside biomedical fields, including mapping new environments, learning interactive behaviors from pedestrian trajectories, and training self-driving cars from driver data, suggest there are many methods left untried in this area.
Using a range of experiments, we have sought to push the boundaries of the level of information that can be extracted using MPT techniques. In some well-defined cases such as particle size, in vitro cell uptake, and in vitro protein corona, we were able to achieve powerful predictive models using neural networks. These models retained their predictive abilities when extended to more complex models such as samples containing mixed particle sizes. Ex vivo slice studies exhibited some utility as well, but variability from slice to slice and from animal to animal limited their applicability. We suggested additional ways that these weaknesses can be overcome, for instance, by combining cell histology datasets with trajectory datasets. The use of trajectories as a form of biological marker can potentially become a powerful diagnostic tool without the need of expensive or complicated reagents. Future experiments could seek to implement nanoparticle movement as a surrogate for tissue breakdown, disease severity, tissue age, altered cellular behavior, or altered protein expression.
Materials and methods
Nanoparticle preparation and characterization
One hundred-nm fluorescent carboxylate (COOH)-modified polystyrene latex (PS) nanoparticles (PS-COOH) (Fisher Scientific, Hampton, NH) were covalently modified with methoxy (MeO)-poly(ethylene glycol) (PEG)-amine (NH2) (5 kDa MW, Creative PEG Works, Winston-Salem, NC) by carboxyl amine reaction.19 Briefly, 50–100 μL of PS-COOH particle suspension was washed and resuspended to 2- to 6-fold dilution in ultrapure water. An excess of MeO-PEG-NH2 was added to the particle suspension and mixed to dissolve the PEG. N-Hydroxysulfosuccinimide (MilliporeSigma, Burlington, MA) was added to a final concentration of 7 mM and 200 mM borate buffer, pH 8.2, was added to a 4-fold dilution of the starting volume. 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Invitrogen, Carlsbad, CA) was added to stoichiometrically complement the added MeO-PEG-NH2. Particle suspensions were placed on a rotary incubator for 4 h at 25 °C and then washed via centrifugation (Amicon Ultra 0.5 mL 100k MWCO; MilliporeSigma) at conditions specified previously.11 Particles were resuspended in ultrapure water to the initial particle volume and stored at 4 °C until use. The hydrodynamic diameter, polydispersity index (PDI), and ζ-potential were measured for COOH- and PEG-coated fluorescent nanoparticles via dynamic light scattering (DLS) (NanoSizer Zeta Series, Malvern Instruments, Malvern, UK, n = 3 measurements per sample). Particles were diluted to ~0.002% solids in filtered (0.45 μm, Whatman, Maidstone, UK) 10 mM NaCl and incubated for 24 h prior to measurement.
Artificial cerebrospinal fluid preparation
Artificial cerebrospinal fluid (ACSF) was chosen to constitute agarose gels to best mimic the brain microenvironment. ACSF was prepared with the addition of the following concentrations of reagents to deionized (DI) water: 119 mM NaCl (MilliporeSigma), 26.2 mM NaHCO3 (MilliporeSigma), 2.5 mM KCl (MilliporeSigma), 1 mM NaH2PO4 (MilliporeSigma), 1.3 mM MgCl2 (MilliporeSigma), and 10 mM glucose (MilliporeSigma). The solution was filtered (0.45 μm) in a sterile environment and stored at 4 °C until use. For individual experiments, aliquots of ACSF were taken and 2 mM CaCl2 (MilliporeSigma) was added. The resulting media was adjusted to pH 7.2 with 0.2 mM HCl.
Agarose gel preparation and MPT for size prediction and gel stiffness studies
Agarose gels were prepared by adding the desired amount of agarose (low electroendosmosis, gel point for 1.5% gel, 36 ± 1.5 °C, MilliporeSigma) to ACSF. For nanoparticle size prediction studies, 0.4% agarose was used for all conditions, where 40 mg agarose was dissolved in 10 mL ACSF. For gel stiffness studies, 0.4, 0.6, 0.8, 1.0, and 1.2-percent agarose was used, corresponding to 40, 60, 80, 100, and 120 mg agarose in 10 mL ACSF, respectively. The agarose–ACSF mixture was heated to 99 °C and mixed well until the agarose was completely dissolved, as indicated by no visible particulates in the solution. 400 μL agarose–ACSF was added to a well in an 8-well chambered coverglass plate (ThermoFisher Scientific, Waltham, MA) and PS-COOH nanoparticles were immediately added and mixed until evenly distributed to achieve a concentration of 0.005% solids. Two samples were prepared for each combination of particle size and gel stiffness. The prepared gels were allowed to set overnight at room temperature.
Five videos were collected per well at 10 Hz and 100× magnification for 6.5 s via fluorescent microscopy using a cMOS camera (Hamamatsu Photonics, Bridgewater, NJ) mounted on a confocal microscope (Nikon Instruments, Melville, NY). Nanoparticle trajectories and trajectory features were calculated via diff_classifier, a self-developed Python package.34 A complete list of trajectory features, including a brief description and method of calculation, is provided as ESI Table S1.†
Rheological characterization of agarose gels
A rheometer (Physica MCR 301, Anton Paar, Graz, Austria) operating in oscillatory mode was used to characterize the mechanical properties of the different weight percent agarose gels (0.4, 0.6, 0.8, and 1.0%). Three samples were prepared for each weight percent. A 25 mm parallel plate attachment (Anton Paar) was operated at a 0.5 mm gap for all experiments. Additionally, the base plate was set to 22 °C 30 min prior to the experiment and held constant throughout the duration of the experimental window.
The linear viscoelastic region was first determined by performing a strain and frequency sweep on 0.4% agarose following a 4 h incubation at 22 °C. For the strain sweep, the frequency was set to 1 Hz, and the storage and loss moduli were measured at various strains (0.1–10%). For the frequency sweep, the strain was set at 2%, and the storage and loss moduli were measured at various frequencies (0.1–10 Hz). The sweeps demonstrated that at 2% strain and 2 Hz, 0.4% agarose is in the linear viscoelastic region because slight changes in strain or frequency do not change the measured storage modulus (Fig. S5†).
Time sweeps were performed on all concentrations of agarose by monitoring the storage and loss moduli for 4 h upon removal from 99 °C stock solution. For 0.4, 0.6, and 0.8% agarose gels, time sweeps were performed at a strain and frequency of 2% and 2 Hz, respectively. For the 1.0% agarose gel, time sweeps were performed at a strain and frequency of 0.5% and 0.5 Hz to remain within the linear viscoelastic region.
In vitro MPT in microglial cell culture for prediction of extracellular versus intracellular diffusion
BV-2 immortalized microglial cells (ATCC, CRL-2469) at passage 8 (P8) were cultured from frozen stock at a seeding density of 2 million cells per cm2 in T-75 flasks (USA Scientific, Ocala, FL), yielding 70–80% confluency in 7 days. Cell culture media (CCM) consisted of 90% Dulbecco’s Modified Eagle Medium (DMEM; ATCC) with 4 mM L-glutamine adjusted to contain 1.5 g L−1 sodium bicarbonate and 4.5 g L−1 glucose, 10% fetal bovine serum (FBS; ATCC), and 1% penicillin/streptomycin (Gibco, ThermoFisher). After eight days, the cells were passaged to P9 and subsequently plated into four 35 mm dishes (ATCC) at a seeding density of 700 000 cells per cm2. PS-COOH and PS-PEG nanoparticles were first prepared in filtered (0.45 μm) 10 mM NaCl solution and mixed with CCM. The cells were incubated with the particles for 30 min prior to imaging. During imaging, cells were maintained at 37 °C and 5% CO2 using Heracell TriGas (ThermoFisher) incubation chamber. Five videos per sample were collected using the described acquisition settings above.
MPT of protein-coated nanoparticles in agarose gels
100 nm PS-COOH and 100 nm PS-PEG nanoparticles were added to separate samples of horse serum (Fisher Scientific) in a 1 : 100 dilution. Particles were incubated in serum for 24 h at 37 °C. In order to ensure similar concentrations of nanoparticles in gels, particles were centrifuged, and the pellet was resuspended in a volume of horse serum equivalent to the original starting volume. Nanoparticle hydrodynamic diameter and zeta potential were measured using methods specified above. The measured hydrodynamic diameter distributions are shown in Fig. 2b. Serum-treated nanoparticles were loaded into 0.4% agarose gels in ACSF as described previously. MPT videos were collected at 10 Hz and 100× magnification for 6.5 s and trajectories generated via diff_classifier.
Protein corona assay
Protein adhesion of serum-incubated nanoparticles was determined via BCA assay (ThermoFisher). Briefly, nanoparticle suspensions of each particle preparation were spun down at 100 000g. The supernatant was discarded, and the particle pellet was resuspended in 10 mM NaCl. BCA working reagent was prepared by mixing 50 parts Reagent A (sodium carbonate, sodium bicarbonate, BCA, sodium tartrate, 0.1 M sodium hydroxide) with 1-part Reagent B (4% cupric sulfate). In a 96-well plate, 25 μL of each nanoparticle sample (n = 3 per sample) was mixed with 200 μL of the working reagent. The cover plate was incubated at 37 °C for 30 min, and UV-Vis measurements were taken at 562 nm. In order to account for nanoparticle fluorescence, serum-incubated UV-Vis measurements were normalized to UV-Vis measurements of serum-free nanoparticles at the same concentration. Measurements were quantified using a 5-point bovine-serum albumin (BSA) calibration curve with concentrations between 5 and 250 μg mL−1.
MPT in rat brain slices
Serum-incubated particles were prepared as described above. All animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of the University of Washington and experiments were approved by the Animal Ethics Committee of the University of Washington, (approval ID: 4383-02). Brain slices were prepared from 30 to 40 g postnatal day 14 (P14) Sprague-Dawley rat pups. Briefly, animals were administered an intraperitoneal injection of pentobarbital (150 mg kg−1). After euthanasia, animals were decapitated and brains rapidly removed and immersed in cold dissecting media consisting of 500 mL HBSS (Fisher Scientific), 1% penicillin-streptomycin (MilliporeSigma), and 3.2 g glucose (MilliporeSigma). 300 μm-thick coronal slices (n = 2 per rat) were prepared using a McIlwain tissue chopper (Ted Pella, Redding, CA). The tissue chopper and razor blades were washed with 70% ethanol prior to sectioning. Slices were placed in a Petri dish containing dissecting media and separated under a surgical dissection microscope. Individual slices were placed on 30 mm cell culture inserts (Fisher Scientific) in 6-well plates (Eppendorf, Hamburg, Germany), filled with 1.5 mL slice culture media containing 200 mL MEM (Fisher Scientific), 100 mL HBSS, 100 mL horse serum (Fisher Scientific), 4 mL Glutamax (Fisher Scientific), and 1% penicillin-streptomycin. Slices were allowed to incubate in sterile conditions at 37 °C and 5% CO2 overnight. 30 min prior to imaging, slices were incubated with either 100 nm PS-COOH nanoparticles, PS-PEG nanoparticles, PS-COOH nanoparticles incubated in horse serum, or PS-PEG nanoparticles incubated in horse serum at a concentration of approximately 0.014% solids. Slices were imaged in a temperature-controlled incubation chamber maintained at 37 °C, 5% CO2, and 80% humidity. 10 videos were collected in the cortex of each slice, and trajectories were calculated via diff_classifier.
FACS cell uptake study
Brain slices (n = 3 per sample) were prepared from 30 to 40 g P14 Sprague-Dawley rat pups. Slices were incubated with either fIuorescently labelled 100 nm PS-COOH nanoparticles, PS-PEG nanoparticles, PS-COOH nanoparticles incubated in horse serum, or PS-PEG nanoparticles incubated in horse serum at a concentration of approximately 0.014% solids for 2 h. Slices were treated with Accutase (Millipore) for 30 min on ice and homogenized. The tissue suspension was filtered through a tissue strainer and diluted in HBSS + 25 mM HEPES (Fisher Scientific). The suspension was spun down at 600g at 4 °C for 5 min and the supernatant discarded. The cell pellet was resuspended in FBS and mixed with a Percoll solution [30% Percoll (GE Healthcare), 3% 10× PBS, 67% HBSS + 25 mM HEPES]. The Percoll cell suspension was overlayed with 1 mL FACS buffer (45 mL HBSS, 5 mL FBS, 0.5 mL HEPES). The cell suspension was spun down at 800g at 4 °C for 30 min. The supernatant was discarded, and the cell pellet was washed 2× with FACS buffer.
The cells were stained with DAPI (Molecular Probes), FITC CD11b (BioLegend), and the CD11b isotype PE Cy7 CD45 (BioLegend). Flow cytometry analysis was performed on the LSR II instrument (BD BioSciences). Laser lines and optical emission filters were arranged as follows: DAPI: 355 nM 20 mW UV laser and 450/50 emission detector; FITC: 488 nM 100 mW blue laser and 530/30 emission filter; Texas RED: 561 nM 150 mW yellow-green laser and 610/20 emission detector. Gating was performed using DAPI, FITC, and particle controls. Each sample measurement included 10 000 events.
MPT analysis and trajectory feature selection
Nanoparticle trajectories were extracted from microscopy videos via a lab-developed Python package diff_classifier for parallelized and reproducible MPT workflows. The diff_classifier package relies on a headless implementation of an ImageJ plugin TrackMate with tracking parameters selected with a combination of user inputs and regression techniques based on input images.35 Diff_classifier also performs trajectory feature extraction based on features from the TrajClassifier ImageJ plugin26 (e.g. alpha, the anomalous diffusion exponent, and boundedness, which quantifies how much a particle is restricted in a circular confined space). These features are an extended feature dataset of Wagner et al. used to classify nanoparticles by their motion type. Features were limited to geometric features, such that particles could be distinguished solely based on their motion, so features based on particle intensity values were excluded. Features were also selected to be rotation- and translation-invariant, so that position or orientation are not taken into account when making predictions.36 Based on 17 features (Table S1†), an additional set of 34 local average and deviation parameters were calculated for 256 total 9 μm × 9 μm tiled rectangular regions in each video.
Principle component analysis (PCA)
A spatial checkerboard train-test split was performed on the geometric feature datasets from each experiment. Every other square (of area 256 × 256 pixels2) in the checkerboard pattern was assigned to either the training dataset or the test dataset. PCA with feature scaling was carried out on the training dataset of experimental dataset. The sampling adequacy of the data was done via the KMO measure and was found to be appropriate (KMO > 0.8).37 Components were extracted to describe >80% of the total variance. The resulting PCA transformation was applied to the test dataset for downstream analysis.
Neural network
In order to evaluate whether trajectories can be used to predict particle properties or parameters of the surrounding tissue microenvironment, single-layer neural networks were trained using scikit-learn’s Multi-Layer Perceptron Classifier using the trajectory features as inputs. An initial grid search was performed to select the best hyperparameters of the neural network. These hyperparameters included number of neurons in the hidden layer (600, 900, 1200), initial learning rate (0.001, 0.005, 0.01), batch size (50, 100, 200), and the L2 regularization term (0.001, 0.01, 0.1), with 10% of the training dataset set aside for cross validation for all models. All models used stochastic gradient descent for weight optimization, the rectified linear unit function for activations in the hidden layer, the log loss cost function, and an adaptive learning rate decreasing the learning rate by a factor of five each time two consecutive epochs fail to decrease training loss by 10−4. After performing the initial hyperparameter search on the nanoparticle size dataset, we selected a hidden layer size of 900, an initial learning rate of 0.005, a batch size of 50, and an L2 regularization term of size 0.001 based on the average recall score in the training dataset. All models were trained on the checkerboard training datasets described above. For the slice study, additional training and testing iterations was performed with an alternate splitting procedure, isolating data from one slice as a test dataset while training on the other three slices to test whether the trained neural network models could be extended to experiments outside the original dataset.
Supplementary Material
Acknowledgements
The authors would like to thank Dr Ariel Rokem for his guidance and insights in applying machine learning techniques to brain-based imaging data. This work was supported by the National Institute of General Medical Sciences (Grant #1 R35 GM124677-01), the eSciences Institute at the University of Washington, and the Data Sciences Initiative in the Department of Chemical Engineering at the University of Washington.
Footnotes
Electronic supplementary information (ESI) available. See DOI: 10.1039/c9nr06327g
Conflicts of interest
There are no conflicts to declare.
References
- 1.Davis ME, Chen ZG and Shin DM, Nat. Rev. Drug Discovery, 2008, 7, 771–782. [DOI] [PubMed] [Google Scholar]
- 2.Bobo D, Robinson KJ, Islam J, Thurecht KJ and Corrie SR, Pharm. Res, 2016, 33, 2373–2387. [DOI] [PubMed] [Google Scholar]
- 3.Curtis C, Zhang MY, Liao R, Wood T and Nance E, WIREs Nanomed. Nanobiotechnol, 2017, 9, e1422. [DOI] [PubMed] [Google Scholar]
- 4.Alexis F, Pridgen E, Molnar LK and Farokhzad OC, Mol. Pharm, 2008, 5, 505–515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Song E, Gaudin A, King AR, Seo YE, Suh HW, Deng Y, Cui J, Tietjen GT, Huttner A and Saltzman WM, Nat. Commun, 2017, 8, 15322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu Q, Swaminathan G, Xiang D, Eberhart C and Hanes J, Sci. Transl. Med, 2012, 4, 149ra119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Duncan GA and Bevan MA, Nanoscale, 2015, 7, 15332–15340. [DOI] [PubMed] [Google Scholar]
- 8.Siepmann J and Gopferich A, Adv. Drug Delivery Rev, 2001, 48, 229–247. [DOI] [PubMed] [Google Scholar]
- 9.Tseng Y, Kole TP and Wirtz D, Biophys. J, 2002, 83, 3162–3176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Yildiz HM, McKelvey CA, Marsac PJ and Carrier RL, J. Drug Targeting, 2015, 23, 768–774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lai SK, O’Hanlon DE, Harrold S, Man ST, Wang YY, Cone R and Hanes J, Proc. Natl. Acad. Sci. U. S. A, 2007, 104, 1482–1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Xu Q, Boylan NJ, Suk JS, Wang YY, Nance EA, Yang JC, McDonnell PJ, Cone RA, Duh EJ and Hanes J, J. Controlled Release, 2013, 167, 76–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wolak DJ and Thorne RG, Mol. Pharm, 2013, 10, 1492–1504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Savin T and Doyle PS, Phys. Rev. E: Stat., Nonlinear, Soft Matter Phys, 2007, 76, 021501. [DOI] [PubMed] [Google Scholar]
- 15.Schuster BS, Suk JS, Woodworth GF and Hanes J, Biomaterials, 2013, 34, 3439–3446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jokerst JV, Lobovkina T, Zare RN and Gambhir SS, Nanomedicine, 2011, 6, 715–728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Curtis C, Toghani D, Wong B and Nance E, Colloids Surf., B, 2018, 170, 673–682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Li H-J, Du J-Z, Du X-J, Xu C-F, Sun C-Y, Wang H-X, Cao Z-T, Yang X-Z, Zhu Y-H and Nie S, Proc. Natl. Acad. Sci. U. S. A, 2016, 113, 4164–4169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Nance E, Methods Mol. Biol, 2017, 1570, 91–104. [DOI] [PubMed] [Google Scholar]
- 20.Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, Landfester K, Schild H, Maskos M, Knauer SK and Stauber RH, Nat. Nanotechnol, 2013, 8, 772–781. [DOI] [PubMed] [Google Scholar]
- 21.Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli B and Dawson KA, J. Am. Chem. Soc, 2011, 133, 2525–2534. [DOI] [PubMed] [Google Scholar]
- 22.Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA and Salvati A, ACS Nano, 2012, 6, 5845–5857. [DOI] [PubMed] [Google Scholar]
- 23.Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdorster G and McGrath JL, Biomaterials, 2009, 30, 603–610. [DOI] [PubMed] [Google Scholar]
- 24.Lesniak A, Salvati A, Santos-Martinez MJ, Radomski MW, Dawson KA and Aberg C, J. Am. Chem. Soc, 2013, 135, 1438–1444. [DOI] [PubMed] [Google Scholar]
- 25.Walkey CD, Olsen JB, Guo H, Emili A and Chan WC, J. Am. Chem. Soc, 2012, 134, 2139–2147. [DOI] [PubMed] [Google Scholar]
- 26.Wagner T, Kroll A, Haramagatti CR, Lipinski HG and Wiemann M, PLoS One, 2017, 12(1), e0170165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Suh J, Wirtz D and Hanes J, Biotechnol. Prog, 2004, 20, 598–602. [DOI] [PubMed] [Google Scholar]
- 28.Chen ZJ, Gillies GT, Broaddus WC, Prabhu SS, Fillmore H, Mitchell RM, Corwin FD and Fatouros PP, J. Neurosurg, 2004, 101, 314–322. [DOI] [PubMed] [Google Scholar]
- 29.Gillies GT, Smith JH, Humphrey JA and Broaddus WC, Technol. Health Care, 2005, 13, 235–243. [PubMed] [Google Scholar]
- 30.Streitberger KJ, Sack I, Krefting D, Pfuller C, Braun J, Paul F and Wuerfel J, PLoS One, 2012, 7, e29888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sack I, Beierbach B, Wuerfel J, Klatt D, Hamhaber U, Papazoglou S, Martus P and Braun J, NeuroImage, 2009, 46, 652–657. [DOI] [PubMed] [Google Scholar]
- 32.Amsden B, Macromolecules, 1999, 32, 874–879. [Google Scholar]
- 33.Verma A and Stellacci F, Small, 2010, 6,12–21. [DOI] [PubMed] [Google Scholar]
- 34.Curtis C, Rokem A and Nance E, J. Open Source Software, 2019, 4(36), 989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Tinevez JY, Perry N, Schindelin J, Hoopes GM, Reynolds GD, Laplantine E, Bednarek SY, Shorte SL and Eliceiri KW, Methods, 2017, 115, 80–90. [DOI] [PubMed] [Google Scholar]
- 36.Helmuth JA, Burckhardt CJ, Koumoutsakos P, Greber UF and Sbalzarini IF, J. Struct. Biol, 2007, 159, 347–358. [DOI] [PubMed] [Google Scholar]
- 37.Zimprich A, Ostereicher MA, Becker L, Dirscherl P, Ernst L, Fuchs H, Gailus-Durner V, Garrett L, Giesert F, Glasl L, Hummel A, Rozman J, de Angelis MH, Vogt-Weisenhorn D, Wurst W and Holter SM, J. Neurosci. Methods, 2018, 300, 77–91. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.